The Food and Drug Administration wants to ramp up the way it regulates smartphone apps linked to prescription drugs — like medication reminders or symptom trackers.

In a new proposal released Monday, the agency said it may treat some apps like drug advertisements — which would allow companies to distribute apps without going through a review process with every update. Right now, the apps aren’t covered by existing regulations.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • The day I use my iPhone device to use with my private healthcare information, is the day that I won’t be alive anymore; meaning that someone has stolen my identity from a dead person. The internet is the last place for anyone to use their personal information to provide even more opportunities for our identity theft increased by the most insane reason for the individuals who expect to have their private lives remain private? I don’t think so. Never going to get the majority of individuals who have a modicum of intellect, to ever consider such an unthethical manner of a private life experience. No I will not be doing anything remotely close to the idiotic proposal such as this.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy